Inner Mongolia Huaxi Biotechnology Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 20,000,000 on November 29, 2021. The transaction will involve participation from new investor Jiangsu Nanfang Medical Co., Ltd. Post the closing, the registered capital of the company will be increased by CNY 2,354,671 and the investor will hold 3.52% stake in the company. The transaction has been approved by the board of directors of the investor in its 28th meeting of the third board of directors, and 25th meeting of the third board of supervisors and is not subject to its shareholders approval.
Jiangsu Nanfang Medical Co., Ltd.
Equities
603880
CNE100002WH0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 CNY | -5.09% | -5.85% | -30.45% |
1st Jan change | Capi. | |
---|---|---|
-30.45% | 151M | |
+9.33% | 27.43B | |
-29.70% | 3.18B | |
-18.01% | 2.53B | |
+7.75% | 2.49B | |
+11.11% | 2.16B | |
-3.87% | 2.03B | |
+7.22% | 1.61B | |
+30.81% | 1.29B | |
+9.01% | 1.17B |
- Stock Market
- Equities
- 603880 Stock
- News Jiangsu Nanfang Medical Co., Ltd.
- Inner Mongolia Huaxi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jiangsu Nanfang Medical Co., Ltd.